12:30pm Discovering & Translating Novel Target ADCs
Time: 12:30 pm
day: Day Two Preclinical & Clinical Development Track
Details:
- Outlining approaches to identifying new targets to differentiate your ADC pipeline and drive your ADC to first-in-class
- Discussing ROR-1 as a target, and the current unmet medical need for ROR-1 associated cancers
- Defining future considerations on X-X conjugation drugs
